- Home
- RGTIW vs XOMAP Comparison
RGTIW vs XOMAP Comparison
Compare RGTIW & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGTIW | XOMAP |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | 164 | 14 |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RGTIW | XOMAP |
|---|---|---|
| Price | $14.36 | $25.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 225.8K | 1.6K |
| Earning Date | 03-11-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,892,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.64 | $25.14 |
| 52 Week High | $46.78 | $27.30 |
Technical Indicators
Market Signals| Indicator | RGTIW | XOMAP |
|---|---|---|
| Relative Strength Index (RSI) | 65.47 | 47.73 |
| Support Level | $10.46 | $25.22 |
| Resistance Level | $15.88 | $25.60 |
| Average True Range (ATR) | 1.83 | 0.10 |
| MACD | 0.69 | 0.04 |
| Stochastic Oscillator | 78.37 | 60.80 |
Price Performance
Historical ComparisonAbout RGTIW Rigetti Computing Inc.
Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.